Evidence map›Paper›PMID 41356085›Full record

ArticleWorld journal of clinical cases2025

Severe venlafaxine poisoning successfully rescued with veno-arterial extracorporeal membrane oxygenation: A case report.

Kurumi Mori, Yoshito Kamijo, Tomoki Doi, Hiroko Abe, Ichiro Takeuchi

Abstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kurumi MoriDepartment of Emergency and Critical Care Medicine, Yokohama City University Medical Center, Yokohama 232-0024, Kanagawa, Japan.
Yoshito KamijoDepartment of Clinical Toxicology, Saitama Medical University, Saitama 3500495, Japan.
Tomoki DoiDepartment of Emergency Medicine, Yokosuka Kyosai Hospital, Yokosuka 238-8558, Kanagawa, Japan.
Hiroko AbeBioDesign Co., Ltd., Tokyo 113-0033, Tōkyō, Japan.
Ichiro TakeuchiDepartment of Emergency and Critical Care Medicine, Yokohama City University School of Medicine, Yokohama 232-0024, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVenlafaxine, a serotonin-norepinephrine reuptake inhibitor, is widely prescribed for the treatment of major depressive disorder. At therapeutic dose, it is generally safe, with a low incidence of adverse effects. However, massive venlafaxine ingestion can cause serious cardiotoxicity, leading to life-threatening arrhythmias. CASE SUMMARY: A 31-year-old woman with a history of depression ingested 14.8 g of venlafaxine along with 6 mg of estazolam and 6 mg of flunitrazepam. On admission, 2 hours post-ingestion, she presented only with mild QTc prolongation. At 4 hours post-ingestion, she developed a generalized tonic-clonic seizure. Following endotracheal intubation, intravenous midazolam infusion was initiated and 50 g of activated charcoal was administered

conclusionIn cases of massive venlafaxine ingestion, continuous intensive monitoring, particularly of QTc, is essential for at least 24 hours, even when initial clinical signs are mild. If refractory ventricular arrhythmias occur, prompt initiation of veno-arterial extracorporeal membrane oxygenation should be considered.

Indexed as

Case reportMassive ingestionQTc prolongationVenlafaxineVeno-arterial extracorporeal membrane oxygenationVentricular fibrillation

Identifiers

PMID41356085
PMCPMC12678968

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.